Henry Schein, Inc. (NASDAQ:HSIC) stock fell by 0.67% following a series of downgraded ratings and lowered price targets from multiple brokerages, indicating a cautious sentiment among analysts regarding the company’s performance.

Henry Schein, Inc

Henry Schein's stock (HSIC) experienced a decline of 0.58% due to a significant reduction in holdings by Universal Beteiligungs und Servicegesellschaft mbH, which sold 25.2% of its stake, alongside other modifications in institutional ownership and lowered price targets from several analysts.

Henry Schein's stock (HSIC) experienced a decline of 0

Henry Schein (HSIC) stock was down 0.58% due to the broader trend of increased CEO turnover among U.S. companies, as pressures from shareholders and boards for improved performance and accountability lead to changes in leadership, reflecting a growing intolerance for underperformance in a competitive market.

Henry Schein (HSIC) stock was down 0

Henry Schein (HSIC) stock dropped by 1.4%, possibly due to market reactions to comparative performance assessments with competitors like Straumann, where despite having a consensus target price indicating potential upside, it faces challenges such as lower earnings compared to Straumann.

Henry Schein (HSIC) stock dropped by 1

Henry Schein, Inc. (NASDAQ:HSIC) stock dropped by 1.4% due to a combination of decreased institutional holdings, lowered price targets from multiple analysts, and weaker-than-expected quarterly revenue compared to analyst estimates.

Henry Schein (HSIC) stock rose 4.53% likely due to increased interest from institutional investors and favorable analyst ratings, including a recent price target increase from Evercore ISI, despite mixed performance reports.

Henry Schein (HSIC) stock rose 4

Henry Schein Inc. (NASDAQ: HSIC) saw a 4.53% increase in stock price, attributed to favorable analyst reports, institutional investment activity, and a recent earnings report that exceeded expectations.

Henry Schein Inc

Henry Schein, Inc. (HSIC) experienced a 0.58% decline in stock value as multiple analysts downgraded their ratings and reduced price targets amid concerns over the company's revenue performance, despite a slight earnings beat in its recent quarterly report.

Henry Schein, Inc. (HSIC) saw a 0.58% decline in its stock price following a downward revision of Q3 2025 earnings estimates by Leerink Partners, which anticipates earnings per share of $1.25 instead of the previously forecasted $1.30.

Henry Schein, Inc. (NASDAQ: HSIC) experienced a 0.58% decline in stock value, which may be attributed to recent downgrades in ratings and price targets from various equities research analysts, including Wall Street Zen lowering their rating from "buy" to "hold," and Piper Sandler and Barrington Research also reducing their price objectives for the stock.

Henry Schein, Inc. (NASDAQ: HSIC) experienced a slight increase of 0.26% in its stock price following a report indicating mixed activities among institutional investors, with some increasing their stakes and others reducing holdings, reflecting a cautiously optimistic outlook surrounding the company's recent earnings performance that surpassed expectations despite a slight revenue decline.

Henry Schein (NASDAQ: HSIC) stock rose 0.26% amidst mixed analyst ratings and price target adjustments, as the company reported better-than-expected quarterly earnings, despite a slight revenue decline. 

The stock went up likely due to its positive earnings report that surpassed analysts' expectations, which can inspire investor confidence, even amidst downgrades in price targets from several firms.

Henry Schein (NASDAQ: HSIC) stock rose 0

Henry Schein, Inc. (NASDAQ: HSIC) stock declined by 1.87% following a reduction in institutional holdings, revised price targets by analysts, and a slight miss in quarterly revenue expectations, despite reporting earnings that exceeded estimates.

Henry Schein, Inc. (NASDAQ:HSIC) experienced a slight decline of 0.06% in its stock price, attributed to a mixture of institutional investors reducing their stakes and slightly disappointing quarterly revenue results compared to expectations.

Henry Schein (HSIC) stock recently decreased by 0.06% following a downgrade in target price and ratings from several analysts, with Robert W. Baird lowering its price target from $82.00 to $72.00, contributing to investor concerns about the company's revenue performance and overall outlook.

Henry Schein (HSIC) stock recently decreased by 0

Henry Schein (NASDAQ:HSIC) stock fell by 3.73% due to lowered price targets from several research firms, despite beating earnings expectations, indicating investor concerns over its revenue performance in a competitive market.

Henry Schein (NASDAQ:HSIC) stock fell by 3

Henry Schein (NASDAQ: HSIC) stock fell by 3.73% due to analysts perceiving its growth potential as less favorable compared to its peers in the "MED/DENTAL – SUPP" industry, reflected in lower earnings and higher valuation metrics relative to competitors.

Henry Schein (NASDAQ: HSIC) stock fell by 3

Henry Schein's stock (NASDAQ:HSIC) declined by 3.73% due to weaker financial performance compared to its rivals, higher valuations, and less favorable growth prospects according to analyst recommendations.

Henry Schein's stock (NASDAQ:HSIC) declined by 3

Henry Schein's stock (NASDAQ:HSIC) fell by 1.49% due to weaker financial performance relative to its peers, with analysts indicating less favorable growth aspects and suggesting that Henry Schein is trading at a higher price-to-earnings ratio compared to other companies in the MED/DENTAL - SUPP industry, which may discourage potential investors.

Henry Schein's stock (NASDAQ:HSIC) fell by 1

Henry Schein, Inc. (HSIC) stock fell by 1.63% due to recent reductions in its target price by multiple analysts, including Wells Fargo and Barrington Research, as well as a decrease in stake by Amalgamated Bank, indicating potential concerns about the company's revenue performance and market sentiment.

Henry Schein (NASDAQ:HSIC) stock was up 0.26% due to recent modifications in institutional investment strategies, including multiple hedge funds buying new positions and adjusting their stakes in the company amidst varied analyst ratings.

Henry Schein (NASDAQ:HSIC) stock was up 0

Henry Schein (NASDAQ: HSIC) stock rose 1.96% likely due to recent changes in institutional investor positions, including significant new investments by firms such as Palestra Capital Management and Lyrical Asset Management, despite mixed analyst ratings and a slight revenue decline in their latest quarterly earnings report.

Henry Schein (NASDAQ: HSIC) stock rose 1

Henry Schein, Inc. (HSIC) stock rose by 0.16% following a 2.8% increase in its shares held by the State of Alaska Department of Revenue and continued interest from institutional investors, indicating positive investor sentiment and confidence in the company's future performance.

Henry Schein (HSIC) stock rose by 1.38% amid mixed activity from institutional investors and analysts adjusting their price targets, while the company reported earnings that slightly surpassed expectations. 

The increase in HSIC stock may be attributed to a combination of positive quarterly earnings that exceeded analyst forecasts, as well as updates from several hedge funds adjusting their positions and the overall interest from institutional investors in the stock.

Henry Schein (HSIC) stock rose by 1

Henry Schein, Inc. (NASDAQ:HSIC) stock rose 1.38% last night, likely due to the company's reported quarterly earnings beating expectations and ongoing interest from institutional investors, despite some recent reductions in stake by other funds.

Henry Schein, Inc. (NASDAQ:HSIC) saw a 0.81% increase in its stock price, partly due to significant investments by various hedge funds and institutional investors, indicating growing confidence in the company's prospects.

Henry Schein, Inc. (HSIC) stock increased by 0.66% due to a favorable "Moderate Buy" average rating from analysts, despite some adjustments in price targets and recent insider sales, suggesting investor confidence in the company’s underlying fundamentals and performance.

Henry Schein, Inc. (NASDAQ:HSIC) experienced a 0.75% increase in its stock price, largely driven by significant boosts in institutional investment, as evidenced by NBC Securities Inc. ramping up its stake by 99,800% during the first quarter, with other hedge funds also increasing their positions in the company.

Henry Schein (HSIC) stock experienced a -0.26% decline, attributed to mixed earnings results and analysts lowering their price targets and ratings on the stock.

Henry Schein (HSIC) stock experienced a -0

Henry Schein, Inc. (NASDAQ: HSIC) saw its stock rise by 1.45% due to significant increases in holdings from institutional investors, including a major 97.2% increase by Mackenzie Financial Corp, indicating strong investor confidence in the company.

Henry Schein (HSIC) stock recently fell by 0.61% following a pattern of insider selling and downgrades by multiple analysts, which may have contributed to investor uncertainty about the company's future performance.

Henry Schein (HSIC) stock recently fell by 0

Henry Schein, Inc. (NASDAQ:HSIC) stock fell by 2.76% largely due to institutional investors reducing their stakes and a mixed earnings report that showed lower revenue than expected along with analysts lowering price targets for the stock.

Henry Schein, Inc. (HSIC) stock fell by 1.93% after Zacks Research downgraded their Q2 2025 earnings per share estimates for the company, leading to lower price targets and ratings from various investment analysts.

Henry Schein, Inc. (NASDAQ:HSIC) experienced a slight decline in stock value by 0.29% due to a series of downgrades in price targets by several equity research analysts, which reflects concerns about achieving future revenue estimates.

Henry Schein, Inc. (NASDAQ: HSIC) stock rose by 1.13% as it continues to receive favorable ratings from analysts, including a recent upgrade from Bank of America, which raised its price target on the stock, contributing to investor optimism.

Henry Schein (NASDAQ:HSIC) stock declined by 2.55% due to various institutional investors adjusting their holdings, with some selling shares, coupled with disappointing quarterly earnings that missed analyst expectations.

Henry Schein (NASDAQ:HSIC) stock declined by 2

Henry Schein (NASDAQ: HSIC) stock declined by 2.03% following a downgrade in Q3 2025 earnings estimates by Leerink Partners, which revised its forecast for earnings per share down from $1.26 to $1.20.

Henry Schein (NASDAQ: HSIC) stock declined by 2

Henry Schein (HSIC) stock decreased by 2.03% due to a recent quarterly earnings report that fell short of analysts' expectations, with earnings per share at $1.19 compared to a consensus estimate of $1.23.

Henry Schein (HSIC) stock decreased by 2

Henry Schein, Inc. (NASDAQ:HSIC) experienced a 2.5% decline in its stock due to institutional investors modifying their holdings, including a notable reduction by CIBC Private Wealth Group LLC, and disappointing earnings results that missed analysts' expectations.

HSIC

Latest News & Analysis